Načítá se...
MSI testing and its role in the management of colorectal cancer
TNM stage remains the key determinant of patient prognosis after surgical resection of colorectal cancer (CRC), and informs treatment decisions. However, there is considerable stage-independent variability in clinical outcome that is likely due to molecular heterogeneity. This variability underscore...
Uloženo v:
| Vydáno v: | Curr Treat Options Oncol |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4594190/ https://ncbi.nlm.nih.gov/pubmed/26031544 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11864-015-0348-2 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|